Observe Medical ASA: Redelivery of lent shares to person closely associated with primary insider and mandatory notification of trade
Oslo, 6 August 2024
Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 17 July 2024 (the "Announcement"), regarding share lending by Ingerø Reiten Investment Company AS in connection with tranche 2 of the private placement of new shares in the Company (the "Private Placement").
The share capital increase pertaining to tranche 2 of the Private Placement has now been registered, as announced by the Company yesterday, and the shares that were lent by Ingerø Reiten Investment Company AS have been redelivered.
Following the return of the lent shares and the allocation of offer shares in tranche 2 of the Private Placement, Ingerø Reiten Investment Company AS holds 43,009,437 shares in the Company (representing approximately 17,51% of the issued share capital and votes). Consequently, Ingerø Reiten Investment Company AS' shareholding has crossed the 15% threshold pursuant to Section 4-2 (1) cf.(3) of the Norwegian Securities Trading Act.
For more information about the redelivery of the lent shares, see the attached form.
This information is subject to the disclosure requirements pursuant to article 19 of the EU Market Abuse Regulation and sections 4-2 and 5-12 of the Norwegian Securities Trading Act.
For further information, please contact:
Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical:
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialisation of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.